[go: up one dir, main page]

WO2005093413A3 - Diagnosis and treatment of preeclampsia - Google Patents

Diagnosis and treatment of preeclampsia Download PDF

Info

Publication number
WO2005093413A3
WO2005093413A3 PCT/US2005/009329 US2005009329W WO2005093413A3 WO 2005093413 A3 WO2005093413 A3 WO 2005093413A3 US 2005009329 W US2005009329 W US 2005009329W WO 2005093413 A3 WO2005093413 A3 WO 2005093413A3
Authority
WO
WIPO (PCT)
Prior art keywords
preeclampsia
diagnosis
treatment
present
provides methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/009329
Other languages
French (fr)
Other versions
WO2005093413A2 (en
Inventor
Irina Buhimschi
Errol Norwitz
Catalin Buhimschi
Lawerence Tsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Brigham and Womens Hospital Inc
Original Assignee
Yale University
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University, Brigham and Womens Hospital Inc filed Critical Yale University
Publication of WO2005093413A2 publication Critical patent/WO2005093413A2/en
Publication of WO2005093413A3 publication Critical patent/WO2005093413A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

In certain embodiments, the present invention provides methods and kits for diagnosing or aiding in the diagnosis of preeclampsia in a female. In other embodiments, the present invention provides methods of identifying a compound that ameliorates or treats preeclampsia as well as methods of identifying biomarkers for preeclampsia in a bodily fluid such as cerebrospinal fluid (CSF).
PCT/US2005/009329 2004-03-22 2005-03-22 Diagnosis and treatment of preeclampsia Ceased WO2005093413A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55534904P 2004-03-22 2004-03-22
US60/555,349 2004-03-22
US63794404P 2004-12-21 2004-12-21
US60/637,944 2004-12-21

Publications (2)

Publication Number Publication Date
WO2005093413A2 WO2005093413A2 (en) 2005-10-06
WO2005093413A3 true WO2005093413A3 (en) 2006-01-05

Family

ID=34966398

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/009329 Ceased WO2005093413A2 (en) 2004-03-22 2005-03-22 Diagnosis and treatment of preeclampsia

Country Status (1)

Country Link
WO (1) WO2005093413A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012047930A2 (en) 2010-10-04 2012-04-12 The Regents Of The University Of California Compositions and methods for treatment of gynecologic cancers
DK2199801T3 (en) 2004-07-14 2013-08-05 Univ California Biomarkers for early detection of ovarian cancer
US7670792B2 (en) 2004-07-14 2010-03-02 The Regents Of The University Of California Biomarkers for early detection of ovarian cancer
US9488655B2 (en) 2004-07-14 2016-11-08 The Regents Of The University Of California Biomarkers for detection of early- and late-stage endometrial cancer
WO2008098734A1 (en) * 2007-02-12 2008-08-21 Stefan Hansson Diagnosis and treatment of preeclampsia
WO2008134881A1 (en) * 2007-05-05 2008-11-13 The University Of Western Ontario Methods for the detection of preeclampsia
CN110187119B (en) * 2008-10-31 2022-07-29 耶鲁大学 Methods and compositions for the detection and treatment of preeclampsia
EP2422203B1 (en) 2009-04-24 2016-12-14 INSERM - Institut National de la Santé et de la Recherche Médicale Method for diagnosing a hemoglobin-related disorder
AU2011231982B2 (en) 2010-03-24 2014-02-20 Preelumina Diagnostics Ab HbF and A1M as early stage markers for preeclampsia
CN104039810A (en) 2011-08-29 2014-09-10 加利福尼亚大学董事会 Use of hdl-related molecules to treat and prevent proinflammatory conditions

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198366A (en) * 1986-03-23 1993-03-30 Technion Research & Development Foundation Ltd. Method for the detection of pregnancy disorders
US5238819A (en) * 1988-12-14 1993-08-24 The Regents Of The University Of California Diagnostic assay for the detection of preeclampsia
US5849474A (en) * 1995-12-06 1998-12-15 Olson; Camilla M. Diagnosis of preeclampsia in mammals
US20010055781A1 (en) * 1996-07-11 2001-12-27 Groome Nigel Patrick Diagnosis of pre-eclampsia
US20030068653A1 (en) * 2000-06-01 2003-04-10 Parrott Jeff A. Determining existence of complications in pregnancies by measuring levels of bioactive lipids
US6642055B1 (en) * 2000-03-31 2003-11-04 Arbogast Pharmaceuticals, Inc. Method for the prediction of preeclampsia and other diseases
WO2004088324A2 (en) * 2003-03-25 2004-10-14 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2004113926A2 (en) * 2003-06-16 2004-12-29 Brian David Owen Owen-Smith Diagnosis of pre-eclampsia

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198366A (en) * 1986-03-23 1993-03-30 Technion Research & Development Foundation Ltd. Method for the detection of pregnancy disorders
US5238819A (en) * 1988-12-14 1993-08-24 The Regents Of The University Of California Diagnostic assay for the detection of preeclampsia
US5849474A (en) * 1995-12-06 1998-12-15 Olson; Camilla M. Diagnosis of preeclampsia in mammals
US20010055781A1 (en) * 1996-07-11 2001-12-27 Groome Nigel Patrick Diagnosis of pre-eclampsia
US6642055B1 (en) * 2000-03-31 2003-11-04 Arbogast Pharmaceuticals, Inc. Method for the prediction of preeclampsia and other diseases
US20030068653A1 (en) * 2000-06-01 2003-04-10 Parrott Jeff A. Determining existence of complications in pregnancies by measuring levels of bioactive lipids
WO2004088324A2 (en) * 2003-03-25 2004-10-14 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2004113926A2 (en) * 2003-06-16 2004-12-29 Brian David Owen Owen-Smith Diagnosis of pre-eclampsia

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BUHIMSCHI IRINA ET AL: "Proteomic profiling of cerebrospinal fluid (CSF) in patients with severe preeclampsia (SPE) suggests subclinical microhemorrhage with functional consequences", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol. 191, no. 6, December 2004 (2004-12-01), & 25TH ANNUAL MEETING OF THE SOCIETY-FOR-MATERNAL-FETAL-MEDICINE; RENO, NV, USA; FEBRUARY 09 -12, 2005, pages S32, XP002346271, ISSN: 0002-9378 *
CHAPPELL L C ET AL: "A LONGITUDINAL STUDY OF BIOCHEMICAL VARIABLES IN WOMEN AT RISK OF PREECLAMPSIA", AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY, MOSBY, ST LOUIS, MO, US, vol. 187, no. 1, July 2002 (2002-07-01), pages 127 - 136, XP001205032, ISSN: 0002-9378 *
LEVINE RICHARD J ET AL: "Circulating angiogenic factors and the risk of preeclampsia", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, vol. 350, no. 7, 12 February 2004 (2004-02-12), pages 672 - 683, XP002314828, ISSN: 1533-4406 *
LIBERATORI S ET AL: "A TWO-DIMENSIONAL PROTEIN MAP OF HUMAN AMNIOTIC FLUID AT 17 WEEK'S GESTATION", ELECTROPHORESIS, WEINHEIM, DE, vol. 18, no. 15, December 1997 (1997-12-01), pages 2816 - 2822, XP008038127, ISSN: 0173-0835 *
NORWITZ ERROL ET AL: "Validation and quantitation of proteomic biomarkers for severe preeclampsia in cerebrospinal fluid", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol. 191, no. 6, December 2004 (2004-12-01), & 25TH ANNUAL MEETING OF THE SOCIETY-FOR-MATERNAL-FETAL-MEDICINE; RENO, NV, USA; FEBRUARY 09 -12, 2005, pages S40, XP002346272, ISSN: 0002-9378 *
NORWITZ ERROL R ET AL: "Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia.", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. SEP 2005, vol. 193, no. 3 Suppl, September 2005 (2005-09-01), pages 957 - 964, XP002346224, ISSN: 0002-9378 *
PUCHADES MAJA ET AL: "Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease.", MOLECULAR BRAIN RESEARCH, vol. 118, no. 1-2, 21 October 2003 (2003-10-21), pages 140 - 146, XP002346222, ISSN: 0169-328X *
UOTILA J T ET AL: "The total peroxyl radical-trapping ability of plasma and cerebrospinal fluid in normal and preeclamptic parturients.", FREE RADICAL BIOLOGY & MEDICINE. MAY 1994, vol. 16, no. 5, May 1994 (1994-05-01), pages 581 - 590, XP002346220, ISSN: 0891-5849 *
WINKLER U ET AL: "URINARY PROTEIN PATTERNS FOR EARLY DETECTION OF PREECLAMPSIA", CONTRIBUTIONS TO NEPHROLOGY, KARGER, BASEL, CH, vol. 68, 1988, pages 227 - 229, XP008038176, ISSN: 0302-5144 *

Also Published As

Publication number Publication date
WO2005093413A2 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
WO2007041245A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
PL1974210T3 (en) Method for diagnosing polycystic kidney disease
WO2004112589A3 (en) Method for the detection of gene transcripts in blood and uses thereof
WO2010059242A3 (en) Neurodegenerative disease diagnostic compositions and methods of use
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
WO2007081720A3 (en) Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
WO2008153705A3 (en) Methods of treating, diagnosing and detecting fgf21-associated disorders
WO2008084331A3 (en) Biomarkers for renal disorders
WO2012021407A3 (en) Biomarkers for stroke
WO2007100919A8 (en) Markers for addiction
WO2007092353A3 (en) Pregnancy biomarker profiles, methods and compositions related thereto
WO2003071927A3 (en) Diagnostics and therapeutics for macular degeneration-related disorders
WO2008055112A3 (en) Methods of treating autism and autism spectrum disorders
WO2005077007A3 (en) Methods of diagnosing and treating pre-eclampsia or eclampsia
WO2009029971A8 (en) Method for diagnosing the metabolic syndrome (ms)
WO2006033907A3 (en) Methods of treating disorders having a component of mercury toxicity
WO2005093413A3 (en) Diagnosis and treatment of preeclampsia
SI2129391T1 (en) Diagnostic method
WO2007047408A3 (en) Promac signature application
WO2006031544A3 (en) Methods for detection of pathogens in red blood cells
WO2006001931A3 (en) Prouroguanylin as therapeutic and diagnostic agents
WO2007028088A3 (en) Methods for enhancing the dewaterability of sludge with alpha-amylase treatment
WO2007032876A3 (en) Biomarkers associated with age-related macular degeneration
WO2009014565A3 (en) Methods for diagnosing and treating astrocytomas
WO2008054598A8 (en) Panel of biomarkers for prediction of fti efficacy

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase